Current options in breast cancer targeted therapies: life after HER-2.

Current options in breast cancer targeted therapies: life after HER-2.

Medicina === Medicine

Bibliographic Details
Main Author:	Rodrigues, Tiago André Moura
Format:	Others
Language:	Portuguese
Published:	Instituto de Ciências Biomédicas Abel Salazar 2011
Subjects:	Porto
Online Access:	http://hdl.handle.net/10216/53412

Similar Items

Current neoadjuvant treatment options for HER2 positive breast cancer
by: Abdel-Razeq H, et al.
Published: (2011-08-01)

"Prognostic Value Of Methilation Markers In Breast Cancer"
by: Martins, Ana Teresa Pinto Teixeira
Published: (2011)

Identifying cancer stem cells in breast tumours: searching for cancer origins
by: Ricardo, Sara Alexandra Vinhas
Published: (2011)

Current Landscape of Targeted Therapy in Hormone Receptor-Positive and HER2-Negative Breast Cancer
by: Samitha Andrahennadi, et al.
Published: (2021-05-01)

Congenital scoliosis due to Hemivertebra: treatment options
by: Gouveia, António Ricardo Frada Tavares
Published: (2011)

Target therapy in treatment of HER2-positive breast cancer
by: A. S. Belokhvostova, et al.
Published: (2016-02-01)

Myelodysplastic Syndromes - Therapeutic options in high-risk patients.
by: Machado, Diogo Alcino de Abreu Ribeiro Carvalho
Published: (2011)

" Objective and Subjective Assessment of Qigong Related Effects in Breast Cancer Patients ".
by: Fernandes, Andreia Sofia Pires
Published: (2011)

Quality of websites providing information on breast and prostate cancer in Portuguese language.
by: Ferreira, Carlos Daniel Macedo
Published: (2012)

Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer
by: Tarah J. Ballinger, et al.
Published: (2018-08-01)

Life after Transcatheter Aortic Valve Implantation: a clinical and echocardiographic appraisal.
by: Gonçalves, Alexandra Maria Gomes da Silva
Published: (2012)

Targeting HER family in HER2-positive metastatic breast cancer: potential biomarkers and novel targeted therapies
by: Inês de Paula Costa Monteiro
Published: (2019)

Avaliação da amplificação do gene HER 2, determinada por Fish e Sish, em casos com score 0/1 + por imunohistoquímica.
by: Pinto, João Filipe Cruz Correia
Published: (2012)

Obstrutive sleep apnea symptoms beyond and snoring: effects of nasal APAP therapy
by: Cruz, Ivo André Castro
Published: (2011)

Relatório de estágio- Os Benefícios da actividade física na população idosa.
by: Neves, Tiago André Machado
Published: (2011)

Perfil de distribuição no rato de nanopartículas de ouro com diferentes revestimentos
by: Morais, Tiago André Coutinho
Published: (2012)

" Aromatase and the Pharmacogenomic Profile - Influence of CYP19A1 polymorphisms in the response of breast cancer patients treated with aromatase inhibitors".
by: Schmid, Heidi
Published: (2012)

Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer
by: T Yu Semiglazova, et al.
Published: (2015-03-01)

Relatório de estágio da unidade curricular de emergência médica
by: Rodrigues, Tiago Henrique Esteves
Published: (2011)

Percepções dos estudantes de Medicina do ICBAS-UP sobre aquisições de competências ao longo do Curso
by: Costa, Tiago André da Silva
Published: (2011)

Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer
by: Yunhua Liu, et al.
Published: (2018-11-01)

Spontaneous epithelial-mesenchymal transition and resistance to HER-2-targeted therapies in HER-2-positive luminal breast cancer.
by: David Lesniak, et al.
Published: (2013-01-01)

O que Mudou no Governo dos Bancos Europeus e Norte-Americanos com a Falência do Lehman Brothers?
by: Moura, Jorge Almiro Rodrigues Casal
Published: (2011)

INCIDÊNCIA, MORTALIDADE E SOBREVIDA DOS CARCINOMAS ORAIS NO DISTRITO DE VIANA DO CASTELO.
by: Sá, André Amado de Moura e
Published: (2011)

Role of targeted therapy in the treatment of HER-2-positive breast cancer brain metastases
by: G. A. Dashyan, et al.
Published: (2016-06-01)

Signalling pathways in basal-like breast carcinomas: a clue on pathogenesis and therapeutical targets.
by: Carvalho, Silvia Teresa Valmor da Silva Pinto de
Published: (2011)

Targeting HER 1 and 2 in breast cancer with lapatinib
by: Gerald M. Higa
Published: (2011-12-01)

Targeting the HER2 Receptor in Metastatic Breast Cancer
by: George Orphanos, et al.
Published: (2012-07-01)

Targeting HER 1 and 2 in breast cancer with lapatinib
by: Gerald M. Higa
Published: (2011-12-01)

HER-2/neu-targeted immunoprevention of breast cancer
by: Sas, Sheena Emm
Published: (2007)

Avaliação do controlo metabólico da Diabetes Mellitus tipo 2 em cuidados de saúde primários.
by: Eusébio, Tiago Alves Gomes
Published: (2012)

Optimal Duration of Neoadjuvant Taxane and Carboplatin Combined With Anti-HER2 Targeted Therapy for HER2-Positive Breast Cancer
by: Yifan Xie, et al.
Published: (2021-06-01)

Role of imatinib in hormone-dependent breast cancer angiogenesis
by: Rocha, Ana Sofia Costa Gomes da
Published: (2011)

Endogenous purines as potential pharmacological targets to control myenteric neurotransmissions
by: Araújo, Margarida Duarte Cerqueira Martins de
Published: (2011)

Vaccine Targets in a Murine Model of Renal Cell Carcinoma.
by: Fonseca, Cátia Isabel Correia dos Reis
Published: (2009)

Predictive factors for chemotherapy-induced oral mucositis in colorectal cancer patients: role of inflammatory related genes polymorphisms.
by: Rodrigues, Andréia Catarina Dias
Published: (2011)

" Qigong Therapy in Physiotherapists in Burnout (Preliminary Study) ".
by: Saganha, João Pedro de Sousa Pinto
Published: (2011)

A novel treatment strategy of HER2-targeted therapy in combination with Everolimus for HR+/HER2- advanced breast cancer patients with HER2 mutations
by: Li, M., et al.
Published: (2022)

HER2 breast cancer therapies: a review
by: Conleth G Murphy, et al.
Published: (2009-06-01)

Neoadjuvant therapy for HER2-positive breast cancer
by: Nikolina Dukić, et al.
Published: (2019-06-01)